Jenna Abelli
InvestorPrincipal at Anzu Partners
Boston, Massachusetts
Writes $3M – $15M checks · typically $8M
About
Jenna Abelli is a Principal at Anzu Partners, where she leads investment diligence and sourcing and supports portfolio companies on product strategy, commercialization, and business development. A chemical engineer by training, she focuses on next-generation chemicals, novel materials, and life sciences, and has led $30M in investments since joining in 2018. She previously worked as a Senior Product and Brand Manager at Cascade Maverik Lacrosse and managed tire and rubber compound development at Continental Tire in Germany, and holds a B.E. in Chemical Engineering from Tufts University.
Invests in
BiotechMedical DevicesNew Materials
Experience
- Anzu PartnersPrincipalcurrent2018 — presentGreater Boston
- ExOneBoard Member, ExOne Global Holdingscurrent2025 — present
- Sofregen Inc.Board Membercurrent2023 — present
- Sofregen Inc.CEO (Investor Secondment)2023 — 2025Framingham, Massachusetts, United States
- Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSAAdvisory Board Membercurrent2023 — present
- BioFlyte, Inc.Board Member2022 — 2026
- CytoTronicsBoard Member2021 — 2026Boston, Massachusetts, United States
- Cascade Maverik Lacrosse, LLCSenior Brand & Product Manager, Women's Lacrosse2014 — 2018Exeter, New Hampshire
- ContinentalProject Leader Tire Line Development2010 — 2014Hannover-Braunschweig-Göttingen-Wolfsburg Region
- U.S. Environmental Protection AgencyPhysical Science Technician2009 — 2010Boston, MA
Education
- Tufts UniversityBachelors of Engineering, Chemical Engineering
- University of AucklandN/A, Chemical Engineering
Skills & more
Languages German · Portuguese · Spanish
- NACD Directorship Certification® — NACD (National Association of Corporate Directors)
From Jenna's professional profile.
Same school
Shared employers
Also worked at ExOne2
Also worked at BioFlyte, Inc.1
Also worked at Continental8
+ 2 more
Also worked at U.S. Environmental Protection Agency12
+ 6 more
Deals · 2
CytotronicsLed round
via Anzu Partners
SofregenLed round
via Anzu Partners
Attribution from SEC filings, press coverage, and firm rosters.




























